Advances in Drug Delivery Systems for Leishmaniasis Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (31 January 2026) | Viewed by 1210
Special Issue Editors
Interests: dendrimers; pharmacy; medicinal chemistry; drug design of candidates for malaria; Chagas disease; leishmaniasis; tuberculosis; drug delivery; nanomaterial
Interests: dendrimers; molecular modification; latency; molecular modeling; chemical and enzymatic stability studies of dendrimeric prodrugs
Interests: polymers; prodrugs; dendrimers; drug design and synthesis; neglected diseases
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit a contribution to this Special Issue “Advances in Drug Delivery Systems for Leishmaniasis Therapy”.
This Special Issue concentrates on the research of advanced systems that are potentially useful for the delivery of drugs or bioactive compounds in the therapy of leishmaniasis, one of the most relevant neglected diseases, which affect many impoverished regions on the planet. Reviews and original research involving new trends and materials used in drug delivery, including smart polymers, dendrimers, nanotubes, and stimuli-responsive or self-immolative systems, among others, as different nanoparticles are strongly expected.
Your contributions are welcome, and we look forward to receiving your interesting manuscripts.
Prof. Dr. Elizabeth Igne Ferreira
Prof. Dr. Jeanine Giarolla
Prof. Dr. Soraya Da Silva Santos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- delivery systems
- leishmanicides
- bioactive compounds in Leishmania sp.
- advanced systems for drug delivery
- oral and topical administration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
